FoU Spenshult

2017-05-01

A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure.

Hambardzumyan K, Saevarsdottir S, Forslind K, Petersson IF, Wallman JK, Ernestam S, Bolce RJ, van Vollenhoven RF. Arthritis Rheumatol. 2017 May;69(5):953-963.

2017-04-18

Rheumatoid arthritis phenotype at presentation differs depending on the number of autoantibodies present.

Derksen VF, Ajeganova S, Trouw LA, van der Helm-van Mil AH, Hafström I, Huizinga TW, Toes RE, Svensson B, van der Woude D.Ann Rheum Dis. 2017 Apr;76(4):716-720. doi: 10.1136/annrheumdis-2016-209794. Epub 2016 Nov 9.PMID: 28283528

2017-01-01

The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor.

Ajeganova S, van Steenbergen HW, Verheul MK, Forslind K, Hafström I, Toes RE, Huizinga TW, Svensson B, Trouw LA, van der Helm-van Mil AH. Ann Rheum Dis. 2017 Jan;76(1):112-118.

2016-12-01

Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.

van Wesemael TJ, Ajeganova S, Humphreys J, Terao C, Muhammad A, Symmons DP, MacGregor AJ, Hafström I, Trouw LA, van der Helm-van Mil AH, Huizinga TW, Mimori T, Toes RE, Matsuda F, Svensson B, Verstappen SM, van der Woude D.Arthritis Res Ther. 2016 Dec 1;18(1):285. doi: 10.1186/s13075-016-1177-9.PMID: 27906045

2016-11-01

Persistently active disease is common in patients with rheumatoid arthritis, particularly in women: a long-term inception cohort study.

Svensson B, Andersson M, Forslind K, Ajeganova S, Hafström I; BARFOT study group. Scand J Rheumatol. 2016 Nov;45(6):448-455.

2016-05-10

The influence of lifestyle habits on quality of life in patients with established rheumatoid arthritis-A constant balancing between ideality and reality.

Malm K, Bremander A, Arvidsson B, Andersson ML, Bergman S, Larsson I.

Int J Qual Stud Health Well-being. 2016 May 10;11:30534. doi: 10.3402/qhw.v11.30534. eCollection 2016.

PMID: 27172513

2016-04-18

Evaluation of the association between anticarbamylated protein antibodies and the longitudinal course of functional ability in rheumatoid arthritis.

Ajeganova S, Svensson B, Huizinga TW, van der Helm-van Mil AH, van Steenbergen HW.Ann Rheum Dis. 2016 Apr;75(4):e14. doi: 10.1136/annrheumdis-2015-208954. Epub 2015 Dec 23.PMID: 26698847

2016-01-28

MRI evidence of persistent joint inflammation and progressive joint damage despite clinical remission during treatment of early rheumatoid arthritis.

Forslind K, Svensson B. Scand J Rheumatol. 2016;45(2):99-102.

2016-01-12

Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts.

Ajeganova S, Humphreys JH, Verheul MK, van Steenbergen HW, van Nies JA, Hafström I, Svensson B, Huizinga TW, Trouw LA, Verstappen SM, van der Helm-van Mil AH.Ann Rheum Dis. 2016 Nov;75(11):1924-1932. doi: 10.1136/annrheumdis-2015-208579. Epub 2016 Jan 12.PMID: 26757747

2015-08-27

Genetic Factors for the Severity of ACPA-negative Rheumatoid Arthritis in 2 Cohorts of Early Disease: A Genome-wide Study.

de Rooy DP, Tsonaka R, Andersson ML, Forslind K, Zhernakova A, Frank-Bertoncelj M, de Kovel CG, Koeleman BP, van der Heijde DM, Huizinga TW, Toes RE, Houwing-Duistermaat JJ, Ospelt C, Svensson B, van der Helm-van Mil AH. J Rheumatol. 2015 Aug;42(8):1383-91.

BARFOT

Adress

Kontakt